SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Lili Boulanger — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientLili Boulanger
Date of birth1893-08-21
IdentifiersMRN HR-ET025-SYN-TD; SSN (made up) 000-25-7731
Document date1915-01-19
AuthorOdile Marchetti-Rowe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for primary care visit for four months of abdominal pain, diarrhea, fevers, and weight loss. [S]

Objective

PHQ-2: 2; Hemoglobin: 10.6 g/dL (low); MCV: 76 fL (low); White cell count: 9.8 10*3/uL; Platelets: 452 10*3/uL (high); CRP: 38 mg/L (high); Fecal calprotectin: 1240 ug/g (high); Albumin: 3.3 g/dL (low); Ferritin: 9 ng/mL (low); Vitamin B12: 310 pg/mL; 25-hydroxyvitamin D: 18 ng/mL (low); ALT: 16 U/L; AST: 19 U/L; Creatinine: 0.7 mg/dL. [S]

Vital Signs

DateMeasureValueUnitProvenance
1915-01-19Body height160cmS
1915-01-19Body weight45kgS
1915-01-19Body mass index (BMI) [Ratio]17.6kg/m2S
1915-01-19Systolic blood pressure104mm[Hg]S
1915-01-19Diastolic blood pressure66mm[Hg]S
1915-01-19Heart rate96/minS
1915-01-19Respiratory rate16/minS
1915-01-19Body temperature37.6CelS
1915-01-19Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1915-01-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]2{score}S
1915-01-19Hemoglobin [Mass/volume] in Blood10.6g/dL12-15.5 g/dLLowS
1915-01-19MCV [Entitic mean volume] in Red Blood Cells by Automated count76fL80-100 fLLowS
1915-01-19Leukocytes [#/volume] in Blood by Automated count9.810*3/uL4-11 10*3/uLNormalS
1915-01-19Platelets [#/volume] in Blood by Automated count45210*3/uL150-400 10*3/uLHighS
1915-01-19C reactive protein [Mass/volume] in Serum or Plasma38mg/L<=5 mg/LHighS
1915-01-19Calprotectin [Mass/mass] in Stool1240ug/g<=50 ug/gHighS
1915-01-19Albumin [Mass/volume] in Serum or Plasma3.3g/dL3.5-5 g/dLLowS
1915-01-19Ferritin [Mass/volume] in Serum or Plasma9ng/mL15-150 ng/mLLowS
1915-01-19Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma310pg/mL200-900 pg/mLNormalS
1915-01-1925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma18ng/mL30-100 ng/mLLowS
1915-01-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma16U/L<=33 U/LNormalS
1915-01-19Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L<=32 U/LNormalS
1915-01-19Creatinine [Mass/volume] in Serum or Plasma0.7mg/dL0.5-1.1 mg/dLNormalS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets by mouth up to every 6 hours as needed for abdominal pain, no more than 3000 mg a day; no nonsteroidal anti-inflammatory drugsOne or two tablets up to every 6 hours as neededOral route1914-12-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Four months of crampy right lower abdominal pain, loose stools up to six times a day including at night, low-grade evening fevers, and loss of 6 kg; inflammatory markers raised; colonoscopy and small-bowel imaging bookedactiveconfirmed R19.7S — Synthetic presenting concern at the index visit, superseded by the diagnosis; the documented symptoms of early 1915 are echoed (D).
Iron deficiency anemia from chronic intestinal blood loss and poor absorption (hemoglobin 10.6 g/dL, MCV 76, ferritin 9)activeconfirmed D50.0S — Synthetic finding at presentation; corrected by intravenous iron.
Moderate protein-calorie malnutrition: BMI 17.6 after losing 6 kg (12 percent of body weight) in four months; albumin 3.3 g/dLactiveconfirmed E44.0S — Synthetic nutritional status at presentation; resolved with treatment and dietitian support.
Vitamin D deficiency (25-hydroxyvitamin D 18 ng/mL)activeconfirmed E55.9S — Synthetic finding at presentation.

Assessment

Plan of Treatment